Psychedelic drugs market are used to enhance or change sensory perceptions, energy levels, thought processes, and to facilitate spiritual experiences. Psychedelic drugs can be categorized into dissociative drugs (such as PCP), empathogens and serotonergic (classic hallucinogens) (such as LSD). These drugs are used in the treatment of major depressive disorder, treatment-resistant depression, panic disorder, post-traumatic stress disorder, and opiate addiction among others. Chemical substances that are used in the psychedelic drugs are a group of LSD, and plants. Psychedelic are sourced from synthetic process (human-made) and plants or mushrooms. Psychedelic drugs has various street names such as LSD which are also known as acid, blotter, dots, sugar, trips and window pane; Ketamine are also known as vitamin K, bump, green, K/Special K, purple and super acid; PCP are also known as angel/angel dust, boat/love boat, peace, killer weed, super grass and ozone.

Psychedelic drugs market has increased with increased number of psychedelic drugs as compared to the past few years and increasing prevalence of depression and mental disorders in the U.S.

Psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR 16.3% in the forecast period of 2020 to 2027 and expected to reach USD 6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth.

To stay ahead of the competition, a thorough idea about the competitive landscape, their product range, their strategies, and future prospects are very valuable. The meticulous efforts accompanied with integrated approaches results into an excellent market research report that drives the decision making process of the business. This U.S. Psychedelic Drugs Market market report provides with CAGR value fluctuation during the forecast period of 2020-2027 for the market. To figure out market landscape, brand awareness, latest trends, possible future issues, industry trends and customer behaviour, the finest market research report is very essential.

Market Drivers and Restraints:

On the basis of source, the market is segmented into synthetic and natural. Synthetic dominates the psychedelic drugs market as all available drugs are derived from synthetic origin. For this reason, the synthetic segment dominates the market and will also grow at a higher rate over the forecasted period.

On the basis of type, the market is segmented into dissociatives, empathogens, and serotonergic (classical psychedelic drugs). The dissociatives segment dominates the psychedelic drugs market as XYREM (sodium oxybate, Jazz Pharmaceuticals Inc.) is the only approved drug of disruptive psychedelics for the treatment of narcolepsy.

On the basis of application, the market is segmented into narcolepsy, treatment-resistant depression, post-traumatic stress disorder (PTSD), major depressive disorder, others. Narcolepsy as a gamma hydroxybutyric acid (GHB) derivative dominates the psychedelic drugs market and primarily uses psychedelic medicine and the drug has been approved for narcolepsy. Due to this reason, the narcolepsy segment dominates the psychedelic drugs market.

On the basis of route of administration, the market is segmented into oral, intranasal, parenteral, others. Oral is dominant in the psychedelic drugs market as Xyrem is the most branded drug available in the market in oral dosage forms. In addition, patient adherence is very important in symptomatic treatment of the disease. Oral administration of the drug is highly convenient for patients as compared to other forms.

 The major players covered in the U.S. Psychedelic Drugs Market

The major players covered in the report are Johnson & Johnson Services, Inc., Jazz Pharmaceuticals, Inc., Celon Pharma SA, COMPASS, Develco pharma schweiz ag , Doughlas pharmaceuticals limited, NeuroRX, Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals, LLC., AVADEL PHARMACEUTICALS, PLC among other players in the U.S. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Major TOC Of U.S. Psychedelic Drugs Market

Chapter One:  U.S. Psychedelic Drugs Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three:  U.S. Psychedelic Drugs Market Competition, by Players

Chapter Four: U.S. Psychedelic Drugs Market Size by Regions

Chapter Five: North America U.S. Psychedelic Drugs Market Revenue by Countries

Chapter Six: Europe U.S. Psychedelic Drugs Market Revenue by Countries

Chapter Seven: Asia-Pacific U.S. Psychedelic Drugs Market Revenue by Countries

Chapter Eight: South America U.S. Psychedelic Drugs Market Revenue by Countries

 Key Report Highlights

Comprehensive pricing analysis based on different product types and regional segments

Market size data in terms of revenue and sales volume

Deep insights about regulatory and investment scenarios of the U.S. Psychedelic Drugs Market    

Analysis of market effect factors and their impact on the forecast and outlook of the U.S. Psychedelic Drugs Market    

The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the U.S. Psychedelic Drugs Market    

A roadmap of growth opportunities available in the U.S. Psychedelic Drugs Market    with the identification of key factors

The exhaustive analysis of various trends of the U.S. Psychedelic Drugs Market    to help identify market developments

Key Questions Answered in Report:

What is the key to the U.S. Psychedelic Drugs Market?

What will the U.S. Psychedelic Drugs Market Demand and what will be Growth?

What are the latest opportunities for U.S. Psychedelic Drugs Market in the future?

What are the strengths of the key players?

Browse Related Reports@

Alopecia Treatment (Hair Loss) Market
Injectable Drug Delivery Market
Electric Vehicle Charging Stations Market

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]